FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068772 [Registered on: 12/06/2024] Trial Registered Prospectively
Last Modified On: 06/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   A study to compare clinical performance of AMBU AURAGAIN and LMA BLOCKBUSTER in adult patients undergoing general anaesthesia for elective surgeries. 
Scientific Title of Study   A prospective randomised study Comparing clinical performance of AMBU AURAGAIN and LMA BLOCKBUSTER in adult patients undergoing general anaesthesia for elective surgeries. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sweta 
Designation  Associate Professor  
Affiliation  LLRM Medical College 
Address  Department of anaesthesiology LLRM Medical College Meerut

Meerut
UTTAR PRADESH
250004
India 
Phone  8750933442  
Fax    
Email  swetaanae@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sweta 
Designation  Associate professor  
Affiliation  LLRM Medical College 
Address  Department of anaesthesiology LLRM Medical College Meerut

Meerut
UTTAR PRADESH
250004
India 
Phone  8750933442  
Fax    
Email  swetaanae@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Smriti Garg 
Designation  Junior Resident  
Affiliation  LLRM Medical College Meerut 
Address  Department of Anaesthesiology LLRM Medical College Meerut

Meerut
UTTAR PRADESH
250004
India 
Phone  9410617435  
Fax    
Email  dr250317@gmail.com  
 
Source of Monetary or Material Support  
Department of anaesthesiology LLRM Medical college Meerut Uttar Pradesh India 250004 
 
Primary Sponsor  
Name  Department of Anaesthesiology 
Address  LLRM Medical College Meerut Uttar Pradesh India 250004 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sweta  LLRM medical college  Department of anaesthesiology LLRM Medical college Meerut UTTAR PRADESH 250004
Meerut
UTTAR PRADESH 
8750933442

swetaanae@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  ASA Grade I and Grade II undergoing general anaesthesia for elective surgeries 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  AMBU AURAGAIN  Laryngeal Mask Airway(LMA), single use made of phthalate free Poluvinyl Chloride(PVC). It is anatomically curved Supra glottic Airway Device(SGAD) which incorporates 90 degrees preformed curvature to approximate airway anatomy which aids in ventilation during general anaesthesia for surgeries less than 2 hrs duration. 
Comparator Agent  LMA BLOCKBUSTER  LMA reusable made up of silicone increasingly used for cases of difficult intubation. It has a short airway tube which has 95degrees angulation to match oropharyngeal curve and a guidance device for successful blind intubation. 
Intervention  SUPRAGLOTTIC AIRWAY DEVICE Insertion  Group of airway devices that can be inserted into the pharynx to allow ventilation, oxygenation, and administration of anaesthetic gases, without the need for endotracheal intubation. duration less than 2 hrs surgery 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. ASA grade I and grade II Patients.
2. Age- 18 to 65 years of either sex.
3. Patients undergoing surgery under general anaesthesia.
4. Anticipated normal airway in preanaesthetic evaluation.
5. Posted for surgery requiring supine position only 
 
ExclusionCriteria 
Details  1. Patients with anticipated difficult airway
2. Anticipated high risk of aspiration (hiatus hernia, full stomach, pregnancy, gastro-oesophageal reflux).
3. Preoperative respiratory tract infection.
4. Patients with history of allergy or sensitivity to any medication, latex or egg. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Oropharyngeal seal pressure(OSP)  Once after insertion of supraglottic airway device 
 
Secondary Outcome  
Outcome  TimePoints 
Number of attempts taken  For successful insertion of device 
Time taken for effective insertion  Upto securing the airway 
Ease of insertion of device and gastric tube placement  During insertion of device 
Hemodynamic parameters (BP, HR, SPO2)  Baseline, every 5 minutes for initial 15 minutes and then every 15 minutes till end of the surgery. 
Post-op complications (Displacement, blood staining, Sore throat, hoarseness, injury)  After extubation 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   26/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is a prospective randomised study comparing clinical performance of AMBU AURAGAIN and LMA BLOCKBUSTER in adult patients undergoing general anaesthesia for elective surgeries of less than 2 hrs duration. 
Close